CGON vs LULU · rev $4.0M vs P/E 17, rev $11.10B
CG Oncology, Inc. Common stock (CGON) versus Lululemon Athletica Inc. (LULU) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported LULU revenue for 2026-02-01 was $11.10B. Net income was $1.58B. Revenue was up 4.9% from 2025-02-02 to 2026-02-01. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
CGON currently screens at market cap $4.74B. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Not investment advice. Open the CGON and LULU stock pages for the full models.
Not investment advice.